PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsIcatibant
Firazyr(icatibant)
Firazyr, Icatibant (icatibant) is a protein pharmaceutical. Icatibant was first approved as Firazyr on 2008-07-11. It is used to treat hereditary angioedemas in the USA. It has been approved in Europe to treat hereditary angioedemas. The pharmaceutical is active against B2 bradykinin receptor. In addition, it is known to target B1 bradykinin receptor.
Download report
Favorite
COVID-19
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
cardiovascular diseasesD002318
hereditary congenital and neonatal diseases and abnormalitiesD009358
skin and connective tissue diseasesD017437
immune system diseasesD007154
Trade Name
FDA
EMA
Firazyr, Icatibant (discontinued: Icatibant)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Icatibant acetate
Tradename
Company
Number
Date
Products
FIRAZYRTakedaN-022150 RX2011-08-25
1 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
firazyrNew Drug Application2024-01-19
icatibantANDA2024-06-17
sajazirANDA2024-02-16
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
hereditary angioedemasEFO_0004131D054179—
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
B: Blood and blood forming organ drugs
— B06: Other hematological agents in atc
— B06A: Other hematological agents in atc
— B06AC: Drugs used in hereditary angioedema
— B06AC02: Icatibant
HCPCS
Code
Description
J1744
Injection, icatibant, 1 mg
Clinical
Clinical Trials
31 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hereditary angioedemasD054179EFO_0004131———1—56
AngioedemaD000799EFO_0005532T78.3——1—56
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameIcatibant
INNicatibant
Description
ICATIBANT
Classification
Protein
Drug classantiasthmatics (bradykinin antagonists)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
N=C(N)NCCC[C@H](NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)[C@H]1Cc2ccccc2CN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1cccs1)NC(=O)CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N)CCCNC(=N)N)C(=O)O
Identifiers
PDB—
CAS-ID130308-48-4
RxCUI—
ChEMBL IDCHEMBL2028850
ChEBI ID—
PubChem CID6918173
DrugBankDB06196
UNII ID7PG89G35Q7 (ChemIDplus, GSRS)
Target
Agency Approved
BDKRB2
BDKRB2
Organism
Homo sapiens
Gene name
BDKRB2
Gene synonyms
BKR2
NCBI Gene ID
Protein name
B2 bradykinin receptor
Protein synonyms
BK-2 receptor
Uniprot ID
Mouse ortholog
Bdkrb2 (12062)
B2 bradykinin receptor (P32299)
Alternate
BDKRB1
BDKRB1
Organism
Homo sapiens
Gene name
BDKRB1
Gene synonyms
BRADYB1
NCBI Gene ID
Protein name
B1 bradykinin receptor
Protein synonyms
BK-1 receptor, bradykinin B1 receptor, bradykinin receptor 1
Uniprot ID
Mouse ortholog
Bdkrb1 (12061)
B1 bradykinin receptor (Q9Z1F4)
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
Firazyr – Takeda
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Firazyr – Shire
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 1,716 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
4,841 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use